SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Clinical Data Announces FDA Acceptance of New Drug Application for Vilazodone for the Treatment of Major Depressive Disorder; Triggers $15.6 Million Payment from Merck Serono